Funding Opportunities Available for High Risk/High Impact Projects
The American Brain Tumor Association (ABTA) is now accepting Letters of Intent (LOI) for its Discovery Research Grant program. LOIs are due no later than Wednesday, October 7, 2015 at 12:00 noon CDT.
Discovery Grants are one-year, $50,000 grants that fund high risk/high impact projects with the potential to change current diagnostic or treatment paradigms for adults and children with brain tumors. These grants specifically encourage novel research at its earliest stages, in the hopes that it spurs additional funding in the future.
"The ABTA Discovery Grant Program provides an opportunity for investigators from science disciplines outside traditional biological fields to propose innovative approaches to brain tumor diagnostics or treatments," said ABTA Chief Science Officer Nicole Willmarth, Ph.D. "Since the Discovery Grant program was launched in 2010, we have supported projects in a variety of focus areas, including immunotherapy, new biomarkers, nanoparticles and stem cell research."
Submission of discovery-driven science and proof-of-concept studies is encouraged, particularly for concepts with little or no history of previous funding.
"With a patient-centric approach to our research funding program, our goal is to continue supporting novel concepts that align with the ABTA's mission and that have the potential to change the way that brain tumors are currently diagnosed and treated," said Willmarth.
For grant details, including eligibility and LOI instructions, applicants can download the Request for Applications (RFA) on the ABTA Funding Opportunities page: http://www.abta.org/grants.
Application questions can be submitted to email@example.com.
ABOUT THE AMERICAN BRAIN TUMOR ASSOCIATION
Founded in 1973, the American Brain Tumor Association was first and is now the only national organization committed to funding brain tumor research and providing education and information on all tumor types and for all age groups. For more information, visit www.abta.org or call 800-886-ABTA (2282).